Telomere shortening in T cells correlates with Alzheimer's disease status

Neurobiology of Aging

Volumn 24, Issue 1, 2003, Pages 77-84

  Panossian, L A ^a   Porter, V R ^a   Valenzuela, H F ^a   Zhu, X ^a   Reback, Erin ^a   Masterman, D ^a   Cummings, J L ^a   Effros, R B ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Immune system; T cells; Telomeres

Indexed keywords

ALZHEIMER DISEASE VACCINE; ANTIGEN; AUTOANTIGEN; CELL MARKER;

ADULT; AGED; ALZHEIMER DISEASE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BLOOD LEVEL; CELL CLONE; CELL DIVISION; CHROMOSOME; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DRUG TARGETING; FEMALE; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MALE; MONOCYTE; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; TELOMERE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ANTIGENS, CD28; ANTIGENS, CD3; ANTIGENS, CD8; APOPTOSIS; B-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HEAT-SHOCK PROTEINS; HEAT-SHOCK RESPONSE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PHYTOHEMAGGLUTININS; PSYCHIATRIC STATUS RATING SCALES; T-LYMPHOCYTES; TELOMERASE; TELOMERE;

EID: 0037213048     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(02)00043-X     Document Type: Article

References (44)

1. Adibzadeh M., Pohla H., Rehbein A., Pawelec G. Long-term culture of monoclonal human T lymphocytes: models for immunosenescence? Mech. Ageing Dev. 83:1995;171-183.
2. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M.et al. Inflammation and Alzheimer's disease. Neurobiol. Aging. 21:2000;383-421.
3. Allsopp R.C., Vaziri H., Patterson C., Goldstein S., Yougli E.V., Futcher A.B. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 89:1992;10114-10118.
4. Benveniste E.N. Cytokine actions in the central nervous system. Cytokine Growth Factor Rev. 9:1998;259-275.
5. Blackburn E. Structure and function of telomeres. Nature. 350:1991;569-573.
6. Blasko I., Marx F., Steiner E., Hartmann T., Grubeck-Loebenstein B. TNFalpha plus IFNgamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs. FASEB J. 13:1999;63-68.
7. Bonaccorso S., Lin A., Song C., Verkerk R., Kenis G., Bosmans E.et al. Serotonin-immune interactions in elderly volunteers and in patients with Alzheimer's disease (DAT): lower plasma tryptophan availability to the brain in the elderly and increased serum interleukin-6 in DAT. Aging (Milano). 10:1998;316-323.
8. Bondy B., Hofmann M., Muller-Spahn F., Witzko M., Hock C. Reduced beta-amyloid response in lymphocytes of patients with Alzheimer's disease. Pharmacopsychiatry. 28:1995;143-146.
9. Campisi J. The role of cellular senescence in skin aging. J. Investig. Dermatol. Symp. Proc. 3:1998;1-5.
10. Campisi J, Dimri G, Hara E. Control of replicative senescence. In: Schneider Jr E, editor. Handbook of the Biology of Aging, 1996.
11. Chang E., Harley C.B. Telomere length as a measure of replicative histories in human vascular tissues. Proc. Natl. Acad. Sci. U.S.A. 92:1995;11190-11194.
12. Doerfler P., Shearman M.S., Perlmutter R.M. Presenilin-dependent gamma-secretase activity modulates thymocyte development. Proc. Natl. Acad. Sci. U.S.A. 98:2001;9312-9317.
13. Eckert A., Schindowski K., Leutner S., Luckhaus C., Touchet N., Czech C.et al. Alzheimer's disease-like alterations in peripheral cells from presenilin-1 transgenic mice. Neurobiol. Dis. 8:2001;331-342.
14. Effros RB. Immune system activity. In: Masoro E, Austad S, editors. Handbook of the Biology of Aging. San Diego: Academic Press, 2001, p. 324-50.
15. Effros R.B. Loss of CD28 expression on T lymphocytes: a marker of replicative senescence. Dev. Compar. Immunol. 21:1997;471-478.
16. Effros R.B. Replicative senescence in the immune system: impact of the Hayflick Limit on T cell function in the elderly. Am. J. Hum. Gen. 62:1998;1003-1007.
17. Effros R.B., Allsopp R., Chiu C.P., Wang L., Hirji K., Harley C.B.et al. Shortened telomeres in the expanded CD28-CD8+ subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS/Fast Track. 10:1996;F17-F22.
18. Effros R.B., Pawelec G. Replicative senescence of T lymphocytes: does the hayflick limit lead to immune exhaustion? Immunol. Today. 18:1997;450-454.
19. Effros R.B., Zhu X., Walford R.L. Stress response of senescent T lymphocytes: reduced hsp70 is independent of the proliferative block. J. Gerontol. 49:1994;B65-B70.
20. Grossmann A., Kukull W.A., Jinneman J.C., Bird T.D., Villacres E.C., Larson E.B.et al. Intracellular calcium response is reduced in CD4+ lymphocytes in Alzheimer's disease and in older persons with Down's syndrome. Neurobiol. Aging. 14:1993;177-185.
21. Itagaki S., McGeer P.L., Akiyama H. Presence of T cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer's disease brain tissue. Neurosci. Lett. 91:1988;259-264.
22. Joachim C.L., Mori H., Selkoe D.J. Amyloid beta-protein deposition in tissues other than brain in Alzheimer's disease. Nature. 341:1989;226-230.
23. Kell S.H., Allman R.M., Harrell L.E., Liu T., Solvason N. Association between Alzheimer's disease and bound autochthonous IgM on T cells. J. Am. Geriatr. Soc. 44:1996;1362-1365.
24. Ledoux S., Rebai N., Dagenais A., Shaw I.T., Nalbantoglu J., Sekaly R.P.et al. Amyloid precursor protein in peripheral mononuclear cells is upregulated with cell activation. J. Immunol. 150:1993;5566-5575.
25. Mayeux R., Tang M.X., Jacobs D.M., Manly J., Bell K., Merchant C.et al. Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease. Ann. Neurol. 46:1999;412-416.
26. Mehta P.D., Pirttila T., Patrick B.A., Barshatzky M., Mehta S.P. Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease. Neurosci. Lett. 304:2001;102-106.
27. Monteiro J., Batliwalla F., Ostrer H., Gregersen P.K. Shortened telomeres in clonaly expanded CD28-CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts. J. Immunol. 156:1996;3587-3590.
28. Nijhuis E.W.P., Oostervink F., Hinloopen B., Rozing J., Nagelkerken L. Differences in dexamethasone-sensitivity between lymphocytes from patients with Alzheimer's disease and patients with multi-infarct dementia. Brain Behav. Immun. 10:1996;115-125.
29. Oshima J., Campisi J., Tannock T.C., Martin G.M. Regulation of c-fos expression in senescing Werner syndrome fibroblasts differs from that observed in senescing fibroblasts from normal donors. J. Cell Physiol. 162:1995;277-283.
30. Pallister C., Jung S.S., Shaw I., Nalbantoglu J., Gauthier S., Cashman N.R. Lymphocyte content of amyloid precursor protein is increased in Down's syndrome and aging. Neurobiol. Aging. 18:1997;97-103.
31. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T.et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse [see comments]. Nature. 400:1999;173-177.
32. Shalit F., Sredni B., Brodie C., Kott E., Huberman M. T lymphocyte subpopulations and activation markers correlate with severity of Alzheimer's disease. Clin. Immunol. Immunopathol. 75:1995;246-250.
33. Stoll G., Jander S. The role of microglia and macrophages in the pathophysiology of the CNS. Prog. Neurobiol. 58:1999;233-247.
34. Trieb K., Ransmayr G., Sgonc R., Lassmann H., Grubeck-Loebenstein B. APP peptides stimulate lymphocyte proliferation in normals, but not in patients with Alzheimer's disease. Neurobiol. Aging. 17:1996;541-547.
35. Valenzuela H, Effros RB. Telomere measurement and replicative senescence. In: Barnett YA, Barnett CR, editors. Aging: Methods and Protocols. Totowa (New Jersey): Humanae Press, 2000.
36. Vaziri H., Schachter F., Uchida I., Wei L., Zhu X., Effros R.et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am. J. Hum. Genet. 52:1993;661-667.
37. von Zglinicki T. Role of oxidative stress in telomere length regulation and replicative senescence. Ann. N.Y. Acad. Sci. 908:2000;99-110.
38. von Zglinicki T., Saretzki G., Deocke W., Lotze C. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp. Cell Res. 220:1995;186-193.
39. Wang E. Regulation of apoptosis resistance and ontogeny of age-dependent diseases. Exp. Gerontol. 32:1997;471-484.
40. Weng N.P., Palmer L.D., Levine B.L., Lane H.C., June C.H., Hodes R.J. Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging. Immunol. Rev. 160:1997;43-54.
41. Weyand C.M., Bryl E., Goronzy J.J. The role of T cells in rheumatoid arthritis. Arch. Immunol. Ther. Exp. (Warsz). 48:2000;429-435.
42. Xu S., Gaskin F. Increased incidence of anti-beta-amyloid autoantibodies secreted by Epstein-Barr virus transformed B cell lines from patients with Alzheimer's disease. Mech. Ageing Dev. 94:1997;213-222.
43. Younkin S.G. Amyloid beta vaccination: reduced plaques and improved cognition. Nat. Med. 7:2001;18-19.
44. Zhu H., Fu W., Mattson M.P. The catalytic subunit of telomerase protects neurons against amyloid beta-peptide-induced apoptosis. J. Neurochem. 75:2000;117-124.